trial

A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients

NCTId NCT00374777
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 450 (actual)
Sponsored by Astellas Pharma Global Development, Inc.
Primary completion 2008-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
450 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2006-08
Primary completion
2008-05
Eligibility
ALL · 20 Years · 64 Years

Interventions & indications

Drugs
zolpidem MRnitrazepam

Sponsors

Astellas Pharma Global Development, Inc.Lead Sponsor

Investigators

1
Use Central ContactStudy Chair

Sites

0 total

Linked catalysts

1
A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and — primary completion2008-05

Facts & assertions

4 sourced
Enrollment
450
Phase
PHASE3
Primary Completion Date
2008-05
Status
COMPLETED
relationships
The graph out of here
drug
zolpidem MR
drug
nitrazepam
drug
lead_sponsor
Astellas Pharma Global Development, Inc.
company
indication
Bipolar Disorder
indication
Sleep Initiation and Maintenance Disorders
indication
Schizophrenia
indication
investigator
Use Central Contact
person